Skip to main content
Haatem Reda, MD, Neurology, Boston, MA

HaatemMostafaRedaMD

Neurology Boston, MA

Neurophysiology

Neurologist at MGH

Dr. Reda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Reda's full profile

Already have an account?

  • Office

    55 Fruit Street
    Massachusetts General Hospital
    Boston, MA 02114
    Phone+1 617-726-2000

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Clinical Neurophysiology, 2013 - 2014
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neurology, 2012 - 2013
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 2008 - 2009
  • New York Medical College
    New York Medical CollegeClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2026
  • ME State Medical License
    ME State Medical License 2015 - 2026
  • NH State Medical License
    NH State Medical License 2018 - 2026
  • KS State Medical License
    KS State Medical License 2022 - 2025
  • MO State Medical License
    MO State Medical License 2022 - 2025
  • MN State Medical License
    MN State Medical License 2009 - 2012
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • ALS Patients Losing Time and Hope as They Wait for Insurers to Cover a Pricey New Drug
    ALS Patients Losing Time and Hope as They Wait for Insurers to Cover a Pricey New DrugMay 21st, 2018